Loading...

Zur Rose Group

DB:ZRE
Snowflake Description

Flawless balance sheet with reasonable growth potential.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
ZRE
DB
CHF793M
Market Cap
  1. Home
  2. DE
  3. Consumer Retailing
Company description

Zur Rose Group AG, an online pharmacy company, wholesales products to medical practitioners under the Zur Rose and DocMorris brands in Germany and Austria. The last earnings update was 35 days ago. More info.


Add to Portfolio Compare Print
ZRE Share Price and Events
7 Day Returns
-0.7%
DB:ZRE
-0.3%
Europe Consumer Retailing
1.5%
DE Market
1 Year Returns
-16.2%
DB:ZRE
1.9%
Europe Consumer Retailing
-6.2%
DE Market
ZRE Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Zur Rose Group (ZRE) -0.7% 4.3% -2.1% -16.2% - -
Europe Consumer Retailing -0.3% -0.1% 2.8% 1.9% -3.1% -8.1%
DE Market 1.5% 6% 8.5% -6.2% 10.7% 15.3%
1 Year Return vs Industry and Market
  • ZRE underperformed the Consumer Retailing industry which returned 1.9% over the past year.
  • ZRE underperformed the Market in Germany which returned -6.2% over the past year.
Price Volatility
Industry
5yr Volatility vs Market
Related Companies

Value

 Is Zur Rose Group undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Zur Rose Group. This is due to cash flow or dividend data being unavailable. The share price is €80.6.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Zur Rose Group's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Zur Rose Group's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:ZRE PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in CHF CHF-6.14
SWX:ROSE Share Price ** SWX (2019-04-23) in CHF CHF91.5
Europe Consumer Retailing Industry PE Ratio Median Figure of 32 Publicly-Listed Consumer Retailing Companies 19.38x
Germany Market PE Ratio Median Figure of 424 Publicly-Listed Companies 19.6x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Zur Rose Group.

DB:ZRE PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= SWX:ROSE Share Price ÷ EPS (both in CHF)

= 91.5 ÷ -6.14

-14.91x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Zur Rose Group is loss making, we can't compare its value to the Europe Consumer Retailing industry average.
  • Zur Rose Group is loss making, we can't compare the value of its earnings to the Germany market.
Price based on expected Growth
Does Zur Rose Group's expected growth come at a high price?
Raw Data
DB:ZRE PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -14.91x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 3 Analysts
75.2%per year
Europe Consumer Retailing Industry PEG Ratio Median Figure of 24 Publicly-Listed Consumer Retailing Companies 1.53x
Germany Market PEG Ratio Median Figure of 269 Publicly-Listed Companies 1.56x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Zur Rose Group, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Zur Rose Group's assets?
Raw Data
DB:ZRE PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in CHF CHF53.38
SWX:ROSE Share Price * SWX (2019-04-23) in CHF CHF91.5
Europe Consumer Retailing Industry PB Ratio Median Figure of 41 Publicly-Listed Consumer Retailing Companies 1.58x
Germany Market PB Ratio Median Figure of 574 Publicly-Listed Companies 1.84x
DB:ZRE PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= SWX:ROSE Share Price ÷ Book Value per Share (both in CHF)

= 91.5 ÷ 53.38

1.71x

* Primary Listing of Zur Rose Group.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Zur Rose Group is overvalued based on assets compared to the Europe Consumer Retailing industry average.
X
Value checks
We assess Zur Rose Group's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Consumer Retailing industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Consumer Retailing industry average (and greater than 0)? (1 check)
  5. Zur Rose Group has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Zur Rose Group expected to perform in the next 1 to 3 years based on estimates from 3 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
75.2%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Zur Rose Group expected to grow at an attractive rate?
  • Zur Rose Group's earnings growth is expected to exceed the low risk savings rate of 0.2%.
Growth vs Market Checks
  • Zur Rose Group's earnings growth is expected to exceed the Germany market average.
  • Zur Rose Group's revenue growth is expected to exceed the Germany market average.
Annual Growth Rates Comparison
Raw Data
DB:ZRE Future Growth Rates Data Sources
Data Point Source Value (per year)
DB:ZRE Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 3 Analysts 75.2%
DB:ZRE Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 3 Analysts 16.2%
Europe Consumer Retailing Industry Earnings Growth Rate Market Cap Weighted Average 12%
Europe Consumer Retailing Industry Revenue Growth Rate Market Cap Weighted Average 3.7%
Germany Market Earnings Growth Rate Market Cap Weighted Average 11.6%
Germany Market Revenue Growth Rate Market Cap Weighted Average 4.8%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:ZRE Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 3 Analyst Estimates (S&P Global) See Below
All numbers in CHF Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:ZRE Future Estimates Data
Date (Data in CHF Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2022-12-31 2,424 68 1
2021-12-31 2,080 51 23 2
2020-12-31 1,844 14 1 3
2019-12-31 1,548 -5 -34 3
DB:ZRE Past Financials Data
Date (Data in CHF Millions) Revenue Cash Flow Net Income *
2018-12-31 1,207 -33 -39
2018-09-30 1,166 -32 -37
2018-06-30 1,125 -30 -36
2018-03-31 1,061 -36
2017-12-31 990 -22 -36
2017-09-30 953 -21 -34
2017-06-30 915 -21 -31
2017-03-31 900 -21
2016-12-31 884 -14 -13
2016-09-30 873 -4
2016-06-30 861 6
2016-03-31 847 4

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Zur Rose Group's earnings are expected to grow significantly at over 20% yearly.
  • Zur Rose Group's revenue is expected to grow by 16.2% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:ZRE Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 3 Analyst Estimates (S&P Global) See Below

All data from Zur Rose Group Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:ZRE Future Estimates Data
Date (Data in CHF Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2022-12-31
2021-12-31 2.62 4.03 1.21 2.00
2020-12-31 0.10 0.85 -0.72 3.00
2019-12-31 -2.65 -0.45 -4.84 2.00
DB:ZRE Past Financials Data
Date (Data in CHF Millions) EPS *
2018-12-31 -6.14
2018-09-30 -5.97
2018-06-30 -5.79
2018-03-31 -5.74
2017-12-31 -6.94
2017-09-30 -7.48
2017-06-30 -8.23
2017-03-31
2016-12-31 -3.60
2016-09-30 -0.83
2016-06-30 1.46
2016-03-31

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Zur Rose Group is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Zur Rose Group's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Europe market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Zur Rose Group has a total score of 4/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Zur Rose Group performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Zur Rose Group's growth in the last year to its industry (Consumer Retailing).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Zur Rose Group does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Zur Rose Group's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Zur Rose Group's 1-year growth to the Europe Consumer Retailing industry average as it is not currently profitable.
Earnings and Revenue History
Zur Rose Group's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Zur Rose Group Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:ZRE Past Revenue, Cash Flow and Net Income Data
Date (Data in CHF Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 1,207.11 -38.97 99.66
2018-09-30 1,166.19 -37.32 95.73
2018-06-30 1,125.28 -35.67 184.22
2018-03-31 1,061.14 -35.54 180.71
2017-12-31 990.45 -36.24 82.55
2017-09-30 952.94 -33.62 113.25
2017-06-30 915.43 -31.00 143.96
2017-03-31 900.12 -21.37 137.71
2016-12-31 883.83 -12.77 135.20
2016-09-30 872.63 -3.57 124.39
2016-06-30 861.42 5.64 113.58
2016-03-31 846.84 3.61 115.65
2015-12-31 838.45 3.45 116.22
2015-09-30 856.57 4.23 57.26
2015-06-30 874.68 5.01 65.33
2015-03-31 897.53 6.08 67.57
2014-12-31 920.39 7.15 2.77
2014-09-30 919.15 -2.77 39.45
2014-06-30 918.53 -12.69 76.13
2014-03-31 917.37 -14.08 78.22
2013-12-31 915.59 -15.46 80.31
2013-09-30 824.77 -6.74 72.00
2013-06-30 733.43 2.01 63.69
2013-03-31 628.78 4.08 52.81
2012-12-31 524.66 6.14 41.92

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Zur Rose Group has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Zur Rose Group has efficiently used its assets last year compared to the Europe Consumer Retailing industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Zur Rose Group improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Zur Rose Group's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Consumer Retailing industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Zur Rose Group has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Zur Rose Group's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Zur Rose Group's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Zur Rose Group is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Zur Rose Group's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Zur Rose Group's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 3.6x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Zur Rose Group Company Filings, last reported 3 months ago.

DB:ZRE Past Debt and Equity Data
Date (Data in CHF Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 443.61 117.23 230.85
2018-09-30 443.61 117.23 230.85
2018-06-30 277.77 0.00 76.03
2018-03-31 277.77 0.00 76.03
2017-12-31 294.22 4.14 107.94
2017-09-30 294.22 4.14 107.94
2017-06-30 88.48 65.65 15.67
2017-03-31 95.06 0.00 24.76
2016-12-31 103.81 59.08 25.39
2016-09-30 103.81 59.08 25.39
2016-06-30 74.01 0.00 22.80
2016-03-31 72.78 62.80 25.51
2015-12-31 72.78 62.80 25.51
2015-09-30 72.78 62.80 25.51
2015-06-30 67.17 0.00 24.22
2015-03-31 67.17 0.00 24.22
2014-12-31 77.35 58.26 21.49
2014-09-30 77.35 58.26 21.49
2014-06-30 74.12 0.00 19.12
2014-03-31 74.12 0.00 19.12
2013-12-31 73.38 58.61 31.56
2013-09-30 73.38 58.61 31.56
2013-06-30 84.60 0.00 30.01
2013-03-31 84.60 0.00 30.01
2012-12-31 86.19 78.31 55.19
  • Zur Rose Group's level of debt (26.4%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (79% vs 26.4% today).
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Zur Rose Group has sufficient cash runway for more than 3 years based on current free cash flow.
  • Zur Rose Group has sufficient cash runway for 2.5 years if free cash flow continues to grow at historical rates of 49% each year.
X
Financial health checks
We assess Zur Rose Group's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Zur Rose Group has a total score of 6/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Zur Rose Group's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Zur Rose Group dividends. Estimated to be 0% next year.
If you bought €2,000 of Zur Rose Group shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Zur Rose Group's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Zur Rose Group's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:ZRE Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 3 Analyst Estimates (S&P Global) See Below
Europe Consumer Retailing Industry Average Dividend Yield Market Cap Weighted Average of 34 Stocks 3.7%
Germany Market Average Dividend Yield Market Cap Weighted Average of 327 Stocks 3%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.8%
Germany Bottom 25% Dividend Yield 25th Percentile 1.4%
Germany Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:ZRE Future Dividends Estimate Data
Date (Data in CHF) Dividend per Share (annual) Avg. No. Analysts
2022-12-31 0.00 1.00
2021-12-31 0.00 2.00
2020-12-31 0.00 3.00
2019-12-31 0.00 3.00
DB:ZRE Past Annualized Dividends Data
Date (Data in CHF) Dividend per share (annual) Avg. Yield (%)
2017-08-23 0.000 0.000
2017-07-06 0.000 0.000

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Zur Rose Group has not reported any payouts.
  • Unable to verify if Zur Rose Group's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Zur Rose Group's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Zur Rose Group has not reported any payouts.
Future Payout to shareholders
  • No need to calculate the sustainability of Zur Rose Group's dividends in 3 years as they are not expected to pay a notable one for Germany.
X
Income/ dividend checks
We assess Zur Rose Group's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Zur Rose Group afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Zur Rose Group has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Zur Rose Group's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Walter Oberhänsli
COMPENSATION CHF1,322,000
AGE 60
TENURE AS CEO 14.3 years
CEO Bio

Mr. Walter Oberhänsli serves as the Chief Executive Officer at Zur Rose Group AG since 2005. and served as its and Executive Director. Mr. Oberhänsli served as Member of the Executive Board. He served as Chairman of the Board at Zur Rose Group AG from 1996 to 2011. He serves as a Executive Director of Zur Rose Group AG since 1993. He practised as an independent lawyer in Kreuzlingen (Canton of Thurgau) until the end of 2004 and studied law at the University of Zurich.

CEO Compensation
  • Walter's compensation has been consistent with company performance over the past year.
  • Walter's remuneration is about average for companies of similar size in Germany.
Management Team

Walter Oberhänsli

TITLE
CEO & Executive Director
COMPENSATION
CHF1M
AGE
60
TENURE
14.3 yrs

Marcel Ziwica

TITLE
CFO & Member of Executive Board
AGE
43
TENURE
4.4 yrs

Olaf Heinrich

TITLE
Head of Germany & Member of the Executive Board
AGE
48

Walter Hess

TITLE
Head of Switzerland & Member of Executive Board
AGE
53

Lisa Lüthi

TITLE
Head of Corporate Communications
Board of Directors Tenure

Average tenure and age of the Zur Rose Group board of directors in years:

6.3
Average Tenure
57.5
Average Age
  • The tenure for the Zur Rose Group board of directors is about average.
Board of Directors

Stefan Feuerstein

TITLE
Chairman of the Board of Directors
COMPENSATION
CHF325K
AGE
63

Walter Oberhänsli

TITLE
CEO & Executive Director
COMPENSATION
CHF1M
AGE
60
TENURE
26.3 yrs

Thomas Schneider

TITLE
Vice Chairman of the Board of Directors
COMPENSATION
CHF163K
AGE
63

Volker Amelung

TITLE
Non-Executive Director
COMPENSATION
CHF145K
AGE
53
TENURE
9.3 yrs

Heinz Baumgartner

TITLE
Non-Executive Director
COMPENSATION
CHF119K
AGE
55
TENURE
1.9 yrs

Vanessa Frey

TITLE
Non-Executive Director
COMPENSATION
CHF119K
AGE
38
TENURE
3.3 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess Zur Rose Group's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Zur Rose Group has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

Zur Rose Group AG, an online pharmacy company, wholesales products to medical practitioners under the Zur Rose and DocMorris brands in Germany and Austria. The company provides medicines management services. It also operates stationary pharmacy shops. The company was formerly known as Zur Rose AG and changed its name to Zur Rose Group AG in May 2015. Zur Rose Group AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland.

Details
Name: Zur Rose Group AG
ZRE
Exchange: DB
Founded: 1993
CHF692,236,967
8,665,403
Website: http://www.zurrosegroup.com
Address: Zur Rose Group AG
Walzmühlestrasse 60,
Frauenfeld,
Thurgau, 8500,
Switzerland
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
SWX ROSE Share Capital SIX Swiss Exchange CH CHF 06. Jul 2017
OTCPK ZRSE.F Share Capital Pink Sheets LLC US USD 06. Jul 2017
DB ZRE Share Capital Deutsche Boerse AG DE EUR 06. Jul 2017
LSE 0RRB Share Capital London Stock Exchange GB CHF 06. Jul 2017
BATS-CHIXE ROSEZ Share Capital BATS 'Chi-X Europe' GB CHF 06. Jul 2017
Number of employees
Current staff
Staff numbers
1,314
Zur Rose Group employees.
Industry
Drug Retail
Consumer Retailing
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/23 22:38
End of day share price update: 2019/04/23 00:00
Last estimates confirmation: 2019/04/23
Last earnings filing: 2019/03/19
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.